Clinical Trial

Anatomo-clinico-biological Profiles in Severe Nasal Polyps

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 10, 2024 (before its estimated May 3, 2026 completion). Its status may not reflect the trial's current state.
Summary
Nasal sinus polyposis is a chronic inflammatory pathology of the nasal cavity and sinus cavities that causes bilateral and multifocal polyp development and has a prevalence of 2 to 4% in the general population. Therapeutic management consists of first-line medical treatment for anti-inflammatory purposes. Local corticosteroid therapy, using nasal sprays, is the background treatment. Surgical management is offered to patients in case of failure of medical treatment. Although effective, surgery does not protect patients from recurrence of symptoms related to regrowth of polyps. Recently, biologics have appeared, which despite its effectiveness, about 20% of patients have a partial or no response to these treatments. There is currently no possibility of determining the probability of response to treatments in patients. It is therefore essential to determine an anatomo-clinico-biological correlation associating the anatomopathological profile, the clinical characteristics and the cytokine signature in order to best guide the patient's management, including the initiation of biotherapy. Indeed, patients, according to their clinical, biological characteristics and the cytokine signature of their polyps will react differently to different treatments, including surgery and biotherapy. This correlation will serve as a predictor of treatment response.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-04-09.
Status change: Not Yet Recruiting → Recruiting 2024-06-07
Trial Details
NCT Number NCT06362122
Lead Sponsor Poitiers University Hospital
Conditions NASAL POLYPS
Enrollment 200 participants
Start Date 2024-06-03
Primary Completion 2026-05-03 (estimated)
Study Completion 2026-10-03 (estimated)
Updated on ClinicalTrials.gov 2024-06-10